Guided Therapeutics (GTHP) Return on Assets (2016 - 2025)
Historic Return on Assets for Guided Therapeutics (GTHP) over the last 14 years, with Q3 2025 value amounting to 2.86%.
- Guided Therapeutics' Return on Assets fell 11400.0% to 2.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.86%, marking a year-over-year decrease of 11400.0%. This contributed to the annual value of 1.59% for FY2024, which is 2000.0% down from last year.
- Latest data reveals that Guided Therapeutics reported Return on Assets of 2.86% as of Q3 2025, which was down 11400.0% from 2.67% recorded in Q2 2025.
- Over the past 5 years, Guided Therapeutics' Return on Assets peaked at 0.99% during Q2 2021, and registered a low of 2.86% during Q3 2025.
- In the last 5 years, Guided Therapeutics' Return on Assets had a median value of 1.72% in 2024 and averaged 1.49%.
- Examining YoY changes over the last 5 years, Guided Therapeutics' Return on Assets showed a top increase of 56800bps in 2021 and a maximum decrease of -32200bps in 2021.
- Quarter analysis of 5 years shows Guided Therapeutics' Return on Assets stood at 1.02% in 2021, then fell by -18bps to 1.2% in 2022, then tumbled by -64bps to 1.97% in 2023, then grew by 6bps to 1.84% in 2024, then tumbled by -55bps to 2.86% in 2025.
- Its last three reported values are 2.86% in Q3 2025, 2.67% for Q2 2025, and 2.08% during Q1 2025.